MedTrace Logo

Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases

NCT02316431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2016-12-16

No results posted yet for this study

Summary

Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.

Conditions

  • Neoplasm Staging

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Patrick Veit-Haibach, MD · University of Zurich

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02316431 on ClinicalTrials.gov